Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction

26 August 2023 (16:15 - 17:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Assistant Professor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail

The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study

Doctor A. Halili (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Influence of cholesterol levels on NSAID-associated risks after myocardial infarction: a nationwide population-based cohort study

Mr M. Basem Abdallah (Aarhus, DK)

Abstract Slides Video

Presentation thumbnail

Empagliflozin in patients with myocardial infarction: an updated meta-analysis

Doctor M. Abouzid (Poznan, PL)

Abstract Slides Video

Presentation thumbnail

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry

Doctor P. Paolisso (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study

Doctor A. Aimo (Pisa, IT)

Abstract Slides

Access the full session

Session thumbnail

Pharmacotherapy in myocardial infarction

The Event

Event poster

ESC Congress 2023

26 August 2023 16:15 CET

You may be interested in

Webinar

Are beta-blockers still indicated after myocardial infarction?

Congress Presentation

Betablockers post-acute myocardial infarction

Congress Presentation

Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources